Quantitative analysis of RBPMS+ RGC counts per retinal subregion (central, mid-, and far-periphery) and the total ST region revealed substantial reductions in RGC count and percent area–ranging from 42–65%–in MCI and AD patients compared to CN individuals (Fig. 1d, e and Suppl. This evidence concerns the gene RBPMS and Alzheimer disease.